<DOC>
	<DOCNO>NCT02803502</DOCNO>
	<brief_summary>In context hemophilia , well know level factor VIII alone reflect clinical phenotype patient accurate way . At equal factor VIII level , certain patient bleed others . The thrombin generation test ( TGT ) test seem provide good prediction overall hemostatic status individual patient . In previous study , investigator establish normal reference value thrombin generation curve child age 6 month 16 year adults . The goal evaluate use test different clinical context severe hemophilia patient particular . A pilot study show patient thrombin generation &lt; 150 severe phenotype , whether receive appropriate prophylaxy thrombin generation superior 150 . Moreover , investigator access software tool allow individually determine pharmacokinetic profile factor VIII inject patient . The factor VIII concentration measure injection 30 minute , 1 hour , 2 hour 24 hour afterwards . The introduction concentration software allow obtain half-life factor give patient , maximum peak , minimum factor level ( though level ) . The injected dosis might sufficient ( disappearance substantial diminution bleeding ) unsufficient ( persist bleeding ) give patient . This study aim : - measure pharmacokinetic profile factor VIII two different method , time-based method chromogenic method - correlate result TGT result obtain time point determine method give best correlation - link clinical symptomatology ( improved symptomatology ) TGT result - determine minimal TGT result link minimal bleeding rate - adapt prophylactic dosis patient personalize way .</brief_summary>
	<brief_title>Does Thrombin Generation Test Performed During Pharmacokinetic Profile Substitutive Factor VIII Bring Benefits Personalized Treatment Pediatric Patients Adult Hemophilia A Patients Under Prophylaxis ?</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patients severe moderate hemophilia , prophylaxis , suffer bleeding . Patients difficult venous access Patients surgery trauma month , patient acute disease ( infection , inflammation )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>thrombin generation test</keyword>
	<keyword>factor VIII</keyword>
	<keyword>hemophilia</keyword>
</DOC>